Verilumia 
Lilly Reports Retatrutide Trial Results Against Ozempic
Eli Lilly said its experimental drug retatrutide produced greater average weight loss and reduced blood sugar more than Ozempic 2 mg in an 80-week Phase 3 trial involving adults with type 2 diabetes. The company...
